On 17 October 2019, orphan designation EU/3/19/2214 was granted by the European Commission to Voisin Consulting S.A.R.L., France, for nirogacestat for the treatment of soft tissue sarcoma.
|Disease / condition||
Treatment of soft tissue sarcoma
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: